Daewoong gets stem cell facility license in Indonesia

South Korea's Daewoong Pharmaceutical announced on Tuesday that its subsidiary Daewoong Biologics Indonesia has obtained a stem cell Lab Operational...

S.Biomedics gets approval for Parkinson's disease clinical trials

South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...

Mezzion Pharma to try again for US FDA approval of drug

South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...

Fed may allow recession to stem inflation: Ex-Boston Fed chief

NEW YORK -- The Federal Reserve will not be able to stem rampant inflation in the US without an economic recession, former Boston Fed President Eric...

Starbucks Korea faces its biggest challenge in 23 years 

Starbucks Korea, the undisputed leader in South Korea’s coffee franchise landscape, is facing the biggest challenge of its 23-year history.&nb...

Military fund to raise payouts with interest rate increases

South Korea’s Military Mutual Aid Association (MMAA) has decided to raise the interest rates of the members’ savings products by 25 to 4...

Medipost acquires Canada’s OmniaBio for CDMO business

Medipost Co., a South Korean biotechnology company, has acquired a 39.6% stake in OmniaBio Inc., a Canada-based cell and gene therapy contract devel...

Korea names IMF official as new central bank head

South Korea on Wednesday nominated veteran International Monetary Fund official Rhee Chang-yong as the country’s new central bank chief, who i...

Korea electronics, auto sectors hit by triple whammy

South Korea's electronics and auto industries, the two main pillars of Asia’s fourth-largest economy, are losing growth momentum. Demand is sl...